Remedium Capital Partners, LLC
Source: SEC Form 13F · as of Mar 2026Remedium Capital Partners, LLC holds 3 biotech & pharma companies tracked by BioSniper, totaling $437.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
3
Total value held
$437.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Spyre Therapeutics, Inc. (SYRE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| SYRESpyre Therapeutics, Inc. | 3,363,558 | $169.7M |
| ORKAOruka Therapeutics, Inc. | 3,454,776 | $169.5M |
| APGEApogee Therapeutics, Inc. | 1,167,182 | $98.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.